BIOMAT Database Logo BIOMAT Database Logo

Spinchter symptoms as predictors of long-term disability in multiple sclerosis. 2007

Margaret L Frazer, and J Thomas Benson, and Clare A Braun Hashemi, and Heidi Lee, and Karen D Rodman, and Oldrich J Kolar

UI MeSH Term Description Entries
D007155 Immunologic Factors Biologically active substances whose activities affect or play a role in the functioning of the immune system. Biological Response Modifier,Biomodulator,Immune Factor,Immunological Factor,Immunomodulator,Immunomodulators,Biological Response Modifiers,Biomodulators,Factors, Immunologic,Immune Factors,Immunological Factors,Modifiers, Biological Response,Response Modifiers, Biological,Factor, Immune,Factor, Immunological,Factors, Immune,Factors, Immunological,Modifier, Biological Response,Response Modifier, Biological
D001743 Urinary Bladder A musculomembranous sac along the URINARY TRACT. URINE flows from the KIDNEYS into the bladder via the ureters (URETER), and is held there until URINATION. Bladder,Bladder Detrusor Muscle,Detrusor Urinae,Bladder Detrusor Muscles,Bladder, Urinary,Detrusor Muscle, Bladder,Detrusor Muscles, Bladder
D001750 Urinary Bladder, Neurogenic Dysfunction of the URINARY BLADDER due to disease of the central or peripheral nervous system pathways involved in the control of URINATION. This is often associated with SPINAL CORD DISEASES, but may also be caused by BRAIN DISEASES or PERIPHERAL NERVE DISEASES. Bladder Disorder, Neurogenic,Neurogenic Bladder,Bladder Neurogenesis,Bladder, Neurogenic,Neurogenic Bladder Disorder,Neurogenic Bladder, Atonic,Neurogenic Bladder, Spastic,Neurogenic Bladder, Uninhibited,Neurogenic Dysfunction of the Urinary Bladder,Neurogenic Urinary Bladder Disorder,Neurogenic Urinary Bladder, Atonic,Neurogenic Urinary Bladder, Spastic,Neurogenic Urinary Bladder, Uninhibited,Neuropathic Bladder,Urinary Bladder Disorder, Neurogenic,Urinary Bladder Neurogenesis,Urinary Bladder Neurogenic Dysfunction,Atonic Neurogenic Bladder,Neurogenesis, Bladder,Neurogenesis, Urinary Bladder,Neurogenic Bladder Disorders,Neurogenic Urinary Bladder,Spastic Neurogenic Bladder,Uninhibited Neurogenic Bladder
D004185 Disability Evaluation Determination of the degree of a physical, mental, or emotional handicap. The diagnosis is applied to legal qualification for benefits and income under disability insurance and to eligibility for Social Security and workmen's compensation benefits. Disability Evaluations,Evaluation, Disability,Evaluations, Disability
D005544 Forecasting The prediction or projection of the nature of future problems or existing conditions based upon the extrapolation or interpretation of existing scientific data or by the application of scientific methodology. Futurology,Projections and Predictions,Future,Predictions and Projections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014551 Urinary Tract The duct which coveys URINE from the pelvis of the KIDNEY through the URETERS, BLADDER, and URETHRA. Tract, Urinary,Tracts, Urinary,Urinary Tracts
D014554 Urination Discharge of URINE, liquid waste processed by the KIDNEY, from the body. Micturition
D020529 Multiple Sclerosis, Relapsing-Remitting The most common clinical variant of MULTIPLE SCLEROSIS, characterized by recurrent acute exacerbations of neurologic dysfunction followed by partial or complete recovery. Common clinical manifestations include loss of visual (see OPTIC NEURITIS), motor, sensory, or bladder function. Acute episodes of demyelination may occur at any site in the central nervous system, and commonly involve the optic nerves, spinal cord, brain stem, and cerebellum. (Adams et al., Principles of Neurology, 6th ed, pp903-914) Multiple Sclerosis, Acute Relapsing,Relapsing-Remitting Multiple Sclerosis,Acute Relapsing Multiple Sclerosis,Remitting-Relapsing Multiple Sclerosis,Multiple Sclerosis, Relapsing Remitting,Multiple Sclerosis, Remitting-Relapsing,Relapsing Remitting Multiple Sclerosis,Remitting Relapsing Multiple Sclerosis

Related Publications

Margaret L Frazer, and J Thomas Benson, and Clare A Braun Hashemi, and Heidi Lee, and Karen D Rodman, and Oldrich J Kolar
Predictors of long-term disability accrual in relapse-onset multiple sclerosis.
July 2016, Annals of neurology,
Margaret L Frazer, and J Thomas Benson, and Clare A Braun Hashemi, and Heidi Lee, and Karen D Rodman, and Oldrich J Kolar
Onset symptoms as predictors of mortality and disability in multiple sclerosis.
November 1984, Acta neurologica Scandinavica,
Margaret L Frazer, and J Thomas Benson, and Clare A Braun Hashemi, and Heidi Lee, and Karen D Rodman, and Oldrich J Kolar
Prediction of long-term disability in multiple sclerosis.
January 2012, Multiple sclerosis (Houndmills, Basingstoke, England),
Margaret L Frazer, and J Thomas Benson, and Clare A Braun Hashemi, and Heidi Lee, and Karen D Rodman, and Oldrich J Kolar
Early Predictors of Disability and Cognition in Multiple Sclerosis Patients: A Long-Term Retrospective Analysis.
January 2023, Journal of clinical medicine,
Margaret L Frazer, and J Thomas Benson, and Clare A Braun Hashemi, and Heidi Lee, and Karen D Rodman, and Oldrich J Kolar
Multiple sclerosis relapses contribute to long-term disability.
November 2019, Acta neurologica Scandinavica,
Margaret L Frazer, and J Thomas Benson, and Clare A Braun Hashemi, and Heidi Lee, and Karen D Rodman, and Oldrich J Kolar
Interferon beta and long-term disability in multiple sclerosis.
May 2013, JAMA neurology,
Margaret L Frazer, and J Thomas Benson, and Clare A Braun Hashemi, and Heidi Lee, and Karen D Rodman, and Oldrich J Kolar
Long-term disability progression of pediatric-onset multiple sclerosis.
June 2019, Neurology,
Margaret L Frazer, and J Thomas Benson, and Clare A Braun Hashemi, and Heidi Lee, and Karen D Rodman, and Oldrich J Kolar
Retinal layer thinning as a biomarker of long-term disability progression in multiple sclerosis.
October 2022, Multiple sclerosis (Houndmills, Basingstoke, England),
Margaret L Frazer, and J Thomas Benson, and Clare A Braun Hashemi, and Heidi Lee, and Karen D Rodman, and Oldrich J Kolar
Interferon beta and long-term disability in multiple sclerosis--reply.
May 2013, JAMA neurology,
Margaret L Frazer, and J Thomas Benson, and Clare A Braun Hashemi, and Heidi Lee, and Karen D Rodman, and Oldrich J Kolar
Prognostic indicators for long-term disability in multiple sclerosis patients.
January 2013, Journal of the neurological sciences,
Copied contents to your clipboard!